Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2018
Tasks of activities of daily living (ADL) are more valuable than the classical neurological examination to assess upper extremity function and mobility in multiple sclerosisCaspar Ep van Munster, Marcus D'Souza, Saskia Steinheimer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 28, 2015
Home-based training to improve manual dexterity in patients with multiple sclerosis: A randomized controlled trialChristian P Kamm, Heinrich P Mattle, René M Müri, et al.
International Journal of MS Care|September 18, 2023
Assessment of Multiple Aspects of Upper Extremity Function Independent From Ambulation in Patients With Multiple SclerosisCaspar E P van Munster, Burggraaff Jessica, Saskia Steinheimer, et al.
Multiple Sclerosis and Related Disorders|November 4, 2024
Self-reports by persons with multiple sclerosis are an adequate surrogate for healthcare provider data on disease-modifying therapy and multiple sclerosis typeMina Stanikić, Julia Braun, Vladeta Ajdacic-Gross, et al.
Headache|April 30, 2025
Swiss Quality of Life and Health Care Impact Assessment in a Real-World Erenumab-Treated Migraine Population: Results over 2 yearsAndreas R Gantenbein, Christian P Kamm, Christoph J Schankin, et al.
Plos One|November 21, 2024
Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approachStefania Iaquinto, Benjamin Victor Ineichen, Anke Salmen, et al.
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in SwitzerlandMarco Kaufmann, Jens Kuhle, Milo A Puhan, et al.
CNS Neuroscience & Therapeutics|November 10, 2018
Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional studyAndrei Miclea, Anke Salmen, Greta Zoehner, et al.
Plos One|February 6, 2014
Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trialChristian P Kamm, Marwan El-Koussy, Sebastian Humpert, et al.
Pageof 9